NO974551L - Bruk av sulbutiamin for å fremskaffe farmasöytiske sammensetninger nyttige i behandling av visse psykomotoriske- og psyko-intellektuelle sykdommer - Google Patents

Bruk av sulbutiamin for å fremskaffe farmasöytiske sammensetninger nyttige i behandling av visse psykomotoriske- og psyko-intellektuelle sykdommer

Info

Publication number
NO974551L
NO974551L NO974551A NO974551A NO974551L NO 974551 L NO974551 L NO 974551L NO 974551 A NO974551 A NO 974551A NO 974551 A NO974551 A NO 974551A NO 974551 L NO974551 L NO 974551L
Authority
NO
Norway
Prior art keywords
sulbutiamine
psychomotor
psycho
treatment
certain
Prior art date
Application number
NO974551A
Other languages
English (en)
Other versions
NO974551D0 (no
NO313684B1 (no
Inventor
Helene Ollat
Alain Le Ridant
Laurent Perret
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO974551D0 publication Critical patent/NO974551D0/no
Publication of NO974551L publication Critical patent/NO974551L/no
Publication of NO313684B1 publication Critical patent/NO313684B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preliminary Treatment Of Fibers (AREA)
NO19974551A 1996-10-04 1997-10-02 Anvendelse av sulbutiamin ved fremstilling av farmasöytiske sammensetninger nyttige i behandling av visse psykomotoriske- ogpsykointellektuelle sykdommer NO313684B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612112A FR2754178B1 (fr) 1996-10-04 1996-10-04 Utilisation de la sulbutiamine pour l'obtention de compositions pharmaceutiques utiles dans le traitement de certains troubles psychomoteurs et psycho-intellectuels

Publications (3)

Publication Number Publication Date
NO974551D0 NO974551D0 (no) 1997-10-02
NO974551L true NO974551L (no) 1998-04-06
NO313684B1 NO313684B1 (no) 2002-11-18

Family

ID=9496363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974551A NO313684B1 (no) 1996-10-04 1997-10-02 Anvendelse av sulbutiamin ved fremstilling av farmasöytiske sammensetninger nyttige i behandling av visse psykomotoriske- ogpsykointellektuelle sykdommer

Country Status (17)

Country Link
US (1) US5863925A (no)
EP (1) EP0834316B1 (no)
JP (1) JP4234218B2 (no)
CN (1) CN1091370C (no)
AT (1) ATE216884T1 (no)
AU (1) AU716329B2 (no)
BR (1) BR9704964A (no)
CA (1) CA2217463C (no)
DE (1) DE69712287T2 (no)
DK (1) DK0834316T3 (no)
ES (1) ES2176642T3 (no)
FR (1) FR2754178B1 (no)
HU (1) HU227542B1 (no)
NO (1) NO313684B1 (no)
NZ (1) NZ328915A (no)
PT (1) PT834316E (no)
ZA (1) ZA978879B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60113731T2 (de) * 2001-01-31 2006-06-29 Pfizer Products Inc., Groton Als inhibitoren von pde4-isozymen geeignete etherderivate
NZ530158A (en) * 2002-12-20 2005-11-25 Therakos Inc Irradiation chamber
US20070185141A1 (en) * 2006-02-09 2007-08-09 Tim Patterson Thiamine composition for enhancement of physical and mental energy, and related method
US9463186B2 (en) 2013-04-15 2016-10-11 Northwestern University Treatment for dopaminergic disorders

Also Published As

Publication number Publication date
US5863925A (en) 1999-01-26
CA2217463C (fr) 2003-04-01
HUP9701606A2 (hu) 1998-06-29
EP0834316A1 (fr) 1998-04-08
NZ328915A (en) 2000-08-25
ZA978879B (en) 1998-04-17
HU227542B1 (en) 2011-08-29
DE69712287D1 (de) 2002-06-06
ES2176642T3 (es) 2002-12-01
NO974551D0 (no) 1997-10-02
CA2217463A1 (fr) 1998-04-04
JPH10130151A (ja) 1998-05-19
JP4234218B2 (ja) 2009-03-04
AU3992897A (en) 1998-04-09
CN1091370C (zh) 2002-09-25
FR2754178A1 (fr) 1998-04-10
HUP9701606A3 (en) 1999-07-28
FR2754178B1 (fr) 2002-08-23
PT834316E (pt) 2002-08-30
DK0834316T3 (da) 2002-08-05
CN1182588A (zh) 1998-05-27
HU9701606D0 (en) 1997-11-28
EP0834316B1 (fr) 2002-05-02
NO313684B1 (no) 2002-11-18
BR9704964A (pt) 1998-10-27
AU716329B2 (en) 2000-02-24
ATE216884T1 (de) 2002-05-15
DE69712287T2 (de) 2002-12-12

Similar Documents

Publication Publication Date Title
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
HK1012554A1 (en) Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
ES2162951T3 (es) Estabilizacion de composiciones de prostaglandina.
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
SE9604786D0 (sv) New compounds
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
TR200001840T2 (tr) Arile bağlı azopolisiklik bileşikler
GB2199747B (en) Fluticasone propionate compositions and their use in bowel diseases.
FI950909A0 (fi) Rasvahappojohdannaisia
SE9604486D0 (sv) Novel formulation
MX9708800A (es) Compuestos biciclicos aromaticos.
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
NO20002649D0 (no) Anvendelse av en blanding av diol og en alfa-hydroksysyre for behandling av hyperkeratotiske hudsykdommer
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
NO974551L (no) Bruk av sulbutiamin for å fremskaffe farmasöytiske sammensetninger nyttige i behandling av visse psykomotoriske- og psyko-intellektuelle sykdommer
EP0745597A3 (en) Novel melatonergic indanyl piperazines or homopiperazines
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
NO970127D0 (no) Topiske sammensetninger for behandling av hudsykdom
BG48345A1 (en) Hepatoprotective means
IT1282951B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia
RS49595B (sr) Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees